Interview

FDA Focus: What Latham's Practice Chair Is Watching

By Jeff Overley (April 2, 2019, 2:22 PM EDT) -- The global co-chair of Latham & Watkins LLP's health and life sciences practice tells Law360 about the legacy left by the U.S. Food and Drug Administration's outgoing commissioner, when it makes sense for companies to sue the FDA, and his nostalgia for the good old days of informal interactions with regulators....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!